JF
RIGL icon

Jump Financial’s Rigel Pharmaceuticals RIGL Stock Holding History

Jump Financial’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-23,022
Closed -$431K – 2148
2025
Q2 		$431K Buy
+23,022
New +$436K ﹤0.01% 1281
2025
Q1 		– Sell
-30,035
Closed -$505K – 1953
2024
Q4 		$505K Buy
30,035
+14,750
+96% +$283K 0.01% 1069
2024
Q3 		$247K Buy
+15,285
New +$180K 0.01% 1384
2022
Q4 		– Sell
-11,494
Closed -$136K – 1964
2022
Q3 		$136K Buy
+11,494
New +$155K 0.01% 1412
2021
Q4 		– Sell
-1,670
Closed -$61K – 1659
2021
Q3 		$61K Buy
+1,670
New +$65.7K ﹤0.01% 1019

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
CLGM
Capitolis Liquid Global Markets New York $15.7B AUM 30.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jump Financial's RIGL Position: Q3 2025 in Review

Jump Financial sold out of Rigel Pharmaceuticals (RIGL) in Q3 2025, closing a stake of 23,022 shares — an estimated $431K sold.

Jump Financial first reported a position in RIGL in Q3 2021 and held it in 5 quarters. The position peaked at $505K in Q4 2024. 169 funds tracked by Wall St. Rank hold RIGL as of Q3 2025.

  • Jump Financial reported no remaining Rigel Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Jump Financial sold 23,022 Rigel Pharmaceuticals shares in Q3 2025, an estimated $431K.
  • Jump Financial first reported a position in Rigel Pharmaceuticals in Q3 2021 and held it in 5 quarters.
  • Jump Financial's Rigel Pharmaceuticals position peaked at $505K in Q4 2024.
  • 169 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2025.

Based on Jump Financial's 13F filing for Q3 2025, filed 13 Nov 2025.